CLASS III Drug recall · Reported 15 Jun 2016 · FDA Enforcement Report

Ceftriaxone for Injection USP, 250mg/vial recalled

Aidarex Pharmaceuticals is recalling Ceftriaxone for Injection USP, 250mg/vial, distributed in Georgia, Indiana. The recall was initiated on 1 Jun 2016 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot#: 47312-1, Exp 01/2018
Quantity recalled10

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0974-2016
FDA event ID
74316
Recalling firm
Aidarex Pharmaceuticals, Corona, CA
Classification
Class III
Status
Terminated
Recall initiated
1 Jun 2016
FDA classified
7 Jun 2016
Reported
15 Jun 2016
Type
Voluntary: Firm initiated
Customers notified by
FAX
Reason category
Potency & Assay
Drug class
Antibiotics

Timeline

1 Jun 2016Recall initiated by company
7 Jun 2016Classified by FDA+6 days
15 Jun 2016Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations: Out of specification (OOS) intermediate in the subsequent processes to manufacture the final API.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

CEFTRIAXONE for Injection USP, 250mg/vial, Rx only, MFG: LUPIN LIMITED INDIA, Packaged by Aidarex Pharmaceuticals, NDC 53217-0117-01

Where it was distributed

IN, GA

GeorgiaIndiana

Questions about this recall

Is Ceftriaxone for Injection USP, 250mg/vial recalled?

Yes. Aidarex Pharmaceuticals recalled Ceftriaxone for Injection USP, 250mg/vial on 1 Jun 2016. The recall is Class III and its status is Terminated. Recall number D-0974-2016.

Why was it recalled?

CGMP Deviations: Out of specification (OOS) intermediate in the subsequent processes to manufacture the final API.

Which lots are affected?

Lot#: 47312-1, Exp 01/2018

Where was it sold?

IN, GA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Aidarex Pharmaceuticals

All 10

Other Ceftriaxone recalls

All 21